文献速递技术与安全乳腺妇产影像PETCTUS

实时超声虚拟导航融合三维PET/CT评估浅表淋巴结

Real-time ultrasound virtual navigation in 3D PET/CT volumes for superficial lymph-node evaluation: innovative fusion examination.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-10-06

本研究为试点研究,纳入2017年1月至2019年5月在本机构检查的乳腺癌或妇科肿瘤患者,将18F-FDG PET/CT与实时超声融合成像用于评估腋窝或腹股沟淋巴结。30例患者30个淋巴结部位中,融合成像在A组10个部位均可行,B组10例中9例完成,C组10例均完成,并能识别目标淋巴结以引导穿刺活检或注射放射性示踪剂行选择性手术切除。作者认为该技术可行,且在PET/CT与超声结果不一致时仍能检出目标淋巴结。

要点

  • 融合成像将PET/CT DICOM图像上传至超声机并与实时超声同步,用于引导浅表淋巴结活检或放射性示踪剂注射。
  • B组为PET/CT可疑或病理但超声不 suspicious 的淋巴结,C组为两者均可疑但受累淋巴结数目不一致。
  • 融合成像在B组10例中成功完成9例,在C组10例中全部完成,A组10个部位均可行。

核心结论

  • 作者认为,结合PET/CT与实时超声的虚拟导航融合成像技术可行,且当PET/CT与超声表现不一致时仍能检出目标淋巴结。
  • 作者认为,融合成像可引导核心针穿刺活检以避免进一步手术诊断操作,或引导注射放射性示踪剂行选择性手术淋巴结切除,从而实现更保留的选择性手术。
  • 作者认为,该创新技术可能为乳腺和妇科肿瘤学开辟多种诊断和治疗机会。

研究设计与样本

  • 本研究为试点研究,纳入2017年1月至2019年5月在本机构检查的乳腺癌和妇科肿瘤患者。
  • 研究分两阶段:第一阶段纳入10例PET/CT与超声均显示可疑淋巴结且大小、形状和形态完全对应的患者(A组);第二阶段纳入20例PET/CT与超声表现不对应的患者,其中10例PET/CT可疑或病理但超声不 suspicious(B组),10例两者均可疑或病理但受累淋巴结数目不对应(C组)。
  • 融合成像方法为将预先采集的PET/CT DICOM图像上传至超声机,并与在淋巴结部位进行的实时超声扫描同步。
  • 共30例患者30个淋巴结部位(22个腹股沟、8个腋窝)接受融合成像评估。

诊断标准与关键数值

  • 第一阶段A组10个淋巴结部位中,融合技术均显示可行。
  • 第二阶段B组10例中9例成功完成融合成像,C组10例均成功完成。
  • 所有组中融合成像均能识别目标淋巴结,引导检查者行核心针穿刺活检或按放射性引导隐匿病变定位技术注射放射性示踪剂以行选择性手术淋巴结切除。

临床应用与阅片要点

  • 作者认为,融合成像可引导核心针穿刺活检,避免进一步手术诊断操作。
  • 作者认为,融合成像可引导注射放射性示踪剂行选择性手术淋巴结切除,实现更保留的选择性手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the feasibility and clinical application of fusion imaging with virtual navigation, combining 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography (PET/CT) with real-time ultrasound imaging, in assessing superficial lymph nodes in breast-cancer and gynecological-cancer patients.

METHODS: This was a pilot study of breast- and gynecological-cancer patients with abnormal uptake of 18 F-FDG by axillary or groin lymph nodes on PET/CT scan, examined at our institution between January 2017 and May 2019. Fusion imaging was performed, uploading preacquired PET/CT DICOM images onto the ultrasound machine and synchronizing them with real-time ultrasound scanning performed at the lymph-node site. In the first phase, we assessed the feasibility and reliability of fusion imaging in a series of 10 patients with suspicious lymph nodes on both PET/CT and ultrasound, and with full correspondence between both techniques in terms of size, shape and morphology of the lymph nodes (Group A). In the second phase, we included 20 patients with non-corresponding findings between PET/CT and ultrasound: 10 patients with lymph nodes that were suspicious or pathological on PET/CT scan but not suspicious on ultrasound assessment (Group B), and 10 patients with suspicious or pathological lymph nodes on both PET/CT and ultrasound but with no correspondence between the two techniques in terms of number of affected lymph nodes (Group C).

RESULTS: In the 30 selected patients, fusion imaging was assessed at 30 lymph-node sites (22 inguinal and eight axillary nodes). In the first phase (Group A), the fusion technique was shown to be feasible in all 10 lymph-node sites evaluated. In the second phase, fusion imaging was completed successfully in nine of 10 cases in Group B and in all 10 cases in Group C. In all groups, fusion imaging was able to identify the target lymph node, guiding the examiner to perform a core-needle aspiration biopsy or to inject radiotracer for selective surgical nodal excision, according to the radio-guided occult lesion localization technique.

CONCLUSION: Fusion imaging with virtual navigation, combining PET/CT and real-time ultrasound imaging, is technically feasible and able to detect target lymph nodes even when PET/CT and ultrasound findings are inconsistent. Fusion imaging can also be used to guide the performance of core-needle aspiration biopsy, avoiding further surgical diagnostic procedures, or the injection of radiotracer for selective surgical nodal excision, enabling more sparing, selective surgery. This innovative technique could open up multiple diagnostic and therapeutic opportunities in breast and gynecological oncology. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Garganese G, Bove S, Fragomeni S, et al. Real-time ultrasound virtual navigation in 3D PET/CT volumes for superficial lymph-node evaluation: innovative fusion examination. Ultrasound Obstet Gynecol. 2021. PMID: 33587289. doi:10.1002/uog.23613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。